Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 76 to 78 of 78 results for menopause

  1. NICE urges further research on the safety and efficacy of two procedures to treat conditions affecting women

    The long-term safety and efficacy is inadequate on two procedures NICE is calling for further evidence on

    News
    Published
    26 May 2021

  2. Women with moderate to severe fibroids set to be offered new one-a-day treatment following final draft guidance from NICE

    Around 4,500 women with uterine fibroids will be eligible for a new oral treatment after NICE recommended relugolix with estradiol and norethisterone acetate (also called Ryeqo and made by Gedeon Ritcher UK) in final draft guidance.

    News
    Published
    13 May 2022

  3. Thousands of people set to benefit from first new treatment for osteoporosis for over a decade

    Thousands of people in England and Wales with severe osteoporosis who are at high risk of fracture are set to benefit from a new treatment – romosozumab – after NICE recommended it for people after menopause in final draft guidance published today (Friday 1 April) by NICE.

    News
    Published
    1 April 2022